Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: | Psychiatry/Psychology
Search Medical Condition
Psychosis Clinical Trials
A listing of Psychosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found (1109) clinical trials
A Washington University research study seeks participants, 35 – 80 years old.
The purpose of this research study is to learn about normal brain function and brain function in various stages of Alzheimer’s disease. There will be 1 baseline visit that will take approximately 7 hours and 1 optional follow up visit (2.5 to 3 years later). Study procedures include PET scans, ...
Teenage Major Depressive Disorder
Clinical Trials of Texas, Inc. is conducting a research study of an investigational medication for major depressive disorder in teenagers. Qualified participants receive study-related medical care from a board-certified physician, exams and evaluations.
Study of a new medication for the treatment of Alzheimer's Disease
The objective of this study is to assess the safety and tolerability of the study drug given orally twice daily for 28 days. The study will also assess the effects of study drug on oral and cerebrospinal fluid biomarkers. The study evaluations include 2 detailed dental examinations and 2 lumbar ...
Fading Memories?
If you or someone you love suffers from Mild Cognitive Impairment due to Alzheimer's Disease, or mild Alzheimer's Disease, you may be eligible to participate in a research study.
Parkinson's Dementia Disease
A clinical research study is underway, evaluating an investigational study drug for adults with Parkinson's Disease who are experiencing a decline in memory and thinking.
Randomized, Double-Blind, Placebo-Controlled, 2-Arm, 6-Month, Brain Imaging and Safety Study of TRx0237 in Subjects With Mild Alzheimer's Disease
The purpose of this study is to determine the safety and efficacy of TRx0237 8 mg/day in the treatment of subjects with mild Alzheimer's Disease compared to placebo.
XanADu: A Phase II, Double-Blind, 12-Week, Randomised, Placebo-Controlled Study to Assess the Safety, Tolerability and Efficacy of Xanamem™ in Subjects With Mild Dementia Due to Alzheimer's Disease (AD).
This is a Phase II, randomised, multi-centre, double-blind, placebo-controlled proof-of-concept study to assess the safety, tolerability and efficacy of oral Xanamem™ once daily in adult subjects with mild dementia due to AD.
Risk Reduction for Alzheimer's Disease
The rrAD study is testing several strategies that may reduce the risk of Alzheimer’s disease in individuals at risk for the disease when compared to usual care. These strategies include: Aerobic exercise Intensive medical management of blood pressure and cholesterol The combination of these two approaches
GN39763: A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY, AND SAFETY STUDY OF MTAU9937A IN PATIENTS WITH PRODROMAL TO MILD ALZHEIMER’S DISEASE
Research Study for Prodromal to Mild Alzheimer's Disease.
I5T-MC-AACG TRAILBLAZER-ALZ Assessment of Safety, Tolerability and Efficacy of LY3002813 Alone and in Combination With LY3202626 in Early Symptomatic Alzheimer’s Disease
This is a study for early to mild Alzheimer’s, testing the safety of LY3002813 with or without LY3202626 and any side effects from the study medicine. This study is also evaluating whether LY3002813 with or without LY3202626 can help slow the mental and functional changes of Alzheimer’s disease.
